Upcoming Events

Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments

WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 — Retia Medical today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Argos Infinity™, the company’s cardiovascular intelligence software platform designed for high-risk surgical and critical care environments across health systems. Argos Infinity builds on Retia’s clinically validated Multi […]

Read More